Brian K P Goh1,2, Lip-Seng Lee3, Ser-Yee Lee1,2, Pierce K H Chow1,2, Chung-Yip Chan1,2, Adrian K H Chiow3. 1. Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore. 2. Duke-NUS Graduate Medical School, Singapore. 3. Hepatopancreatobiliary Unit, Department of General Surgery, Changi General Hospital, Singapore.
Abstract
BACKGROUND: Presently, the adoption of laparoscopic hepatectomy is rapidly increasingly worldwide. However, the application of robotic hepatectomy (RH) remains limited and its role remains undefined today. METHODS: A retrospective review of 43 consecutive patients who underwent RH at two institutions in the Singapore Health Services Group. RESULTS: Forty-three consecutive patients underwent 48 resections during the study period. Seven (16.3%) patients underwent major resections and seven (16.3%) underwent right posterior sectionectomies. Nineteen (44.2%) patients had tumours located in the difficult posterosuperior segments, five had multiple resections and three underwent repeat resections for recurrent tumours. RH was performed for malignant tumours in 32 (74%) patients and 16 (37.2%) had cirrhosis. Seven RH was performed with other concomitant procedures including three colectomies, three hilar lymphadenectomies and one portal vein ligation. The median operation time was 360 min (range 75-825) and the median blood loss was 300 mL (range 25-4500). There was one (2.3%) open conversion for bleeding. The median post-operative stay was 4 days (range 2-33) and there was one (2.3%) readmission. There was one (2.3%) major (>grade 2 morbidity) in a patient with concomitant anterior resection who underwent reoperation for anastomotic leak. There was no 90 day/in-hospital mortality. Comparison between RH for tumours in the anterolateral segments versus posterosuperior segments demonstrated no significant difference in perioperative outcomes. CONCLUSION: Our initial experience demonstrated that RH is safe, feasible and associated with excellent post-operative outcomes. It can be performed successfully with low morbidity even for complex resections such as major hepatectomies, posterior sectionectomies, tumours in difficult posterosuperior segments and repeat liver resections.
BACKGROUND: Presently, the adoption of laparoscopic hepatectomy is rapidly increasingly worldwide. However, the application of robotic hepatectomy (RH) remains limited and its role remains undefined today. METHODS: A retrospective review of 43 consecutive patients who underwent RH at two institutions in the Singapore Health Services Group. RESULTS: Forty-three consecutive patients underwent 48 resections during the study period. Seven (16.3%) patients underwent major resections and seven (16.3%) underwent right posterior sectionectomies. Nineteen (44.2%) patients had tumours located in the difficult posterosuperior segments, five had multiple resections and three underwent repeat resections for recurrent tumours. RH was performed for malignant tumours in 32 (74%) patients and 16 (37.2%) had cirrhosis. Seven RH was performed with other concomitant procedures including three colectomies, three hilar lymphadenectomies and one portal vein ligation. The median operation time was 360 min (range 75-825) and the median blood loss was 300 mL (range 25-4500). There was one (2.3%) open conversion for bleeding. The median post-operative stay was 4 days (range 2-33) and there was one (2.3%) readmission. There was one (2.3%) major (>grade 2 morbidity) in a patient with concomitant anterior resection who underwent reoperation for anastomotic leak. There was no 90 day/in-hospital mortality. Comparison between RH for tumours in the anterolateral segments versus posterosuperior segments demonstrated no significant difference in perioperative outcomes. CONCLUSION: Our initial experience demonstrated that RH is safe, feasible and associated with excellent post-operative outcomes. It can be performed successfully with low morbidity even for complex resections such as major hepatectomies, posterior sectionectomies, tumours in difficult posterosuperior segments and repeat liver resections.
Authors: Adrian K H Chiow; David Fuks; Gi-Hong Choi; Nicholas Syn; Iswanto Sucandy; Marco V Marino; Mikel Prieto; Charing C Chong; Jae Hoon Lee; Mikhail Efanov; T Peter Kingham; Sung Hoon Choi; Robert P Sutcliffe; Roberto I Troisi; Johann Pratschke; Tan-To Cheung; Xiaoying Wang; Rong Liu; Mathieu D'Hondt; Chung-Yip Chan; Chung Ngai Tang; Ho-Seong Han; Brian K P Goh Journal: Br J Surg Date: 2021-12-01 Impact factor: 6.939
Authors: Tan-To Cheung; Xiaoying Wang; Mikhail Efanov; Rong Liu; David Fuks; Gi-Hong Choi; Nicholas L Syn; Charing C Chong; Iswanto Sucandy; Adrian K H Chiow; Marco V Marino; Mikel Gastaca; Jae Hoon Lee; T Peter Kingham; Mathieu D'Hondt; Sung Hoon Choi; Robert P Sutcliffe; Ho-Seong Han; Chung Ngai Tang; Johann Pratschke; Roberto I Troisi; Brian K P Goh Journal: Hepatobiliary Surg Nutr Date: 2021-10 Impact factor: 7.293
Authors: Ye-Xin Koh; Pallavi Basu; Yi-Xin Liew; Jin-Yao Teo; Juinn-Huar Kam; Ser-Yee Lee; Peng-Chung Cheow; Premaraj Jeyaraj; Pierce K H Chow; Alexander Y F Chung; London L P J Ooi; Chung-Yip Chan; Brian K P Goh Journal: World J Surg Date: 2019-12 Impact factor: 3.352
Authors: Brian K P Goh; Ser-Yee Lee; Jin-Yao Teo; Juinn-Huar Kam; Prema-Raj Jeyaraj; Peng-Chung Cheow; Pierce K H Chow; London L P J Ooi; Alexander Y F Chung; Chung-Yip Chan Journal: Surg Endosc Date: 2018-07-02 Impact factor: 4.584
Authors: Hui Jun Lim; Adrian Kah Heng Chiow; Lip Seng Lee; Siong San Tan; Brian Kp Goh; Ye Xin Koh; Chung Yip Chan; Ser Yee Lee Journal: Singapore Med J Date: 2019-11-04 Impact factor: 1.858
Authors: Ken Min Chin; Darren W Q Chua; Ser Yee Lee; Chung Yip Chan; Brian K P Goh Journal: J Minim Access Surg Date: 2021 Jan-Mar Impact factor: 1.407
Authors: Manuel Durán; Javier Briceño; Ana Padial; Ferdinando Massimiliano Anelli; Juan Manuel Sánchez-Hidalgo; María Dolores Ayllón; Rafael Calleja-Lozano; Carmen García-Gaitan Journal: World J Hepatol Date: 2022-01-27
Authors: Moritz Schmelzle; Linda Feldbrügge; Santiago Andres Ortiz Galindo; Simon Moosburner; Anika Kästner; Felix Krenzien; Christian Benzing; Matthias Biebl; Robert Öllinger; Thomas Malinka; Wenzel Schöning; Johann Pratschke Journal: Surg Endosc Date: 2022-05-31 Impact factor: 3.453